foxo4-dri senolytic peptide mechanism regulates endothelial cell senescence via the P53 signaling pathway Buy FOXO4-DRI (Proxofim) - Senolytic
Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI Peptide 10 mg
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20




